Effects of intragastric balloon on obesity in obese Korean women for 6 months post removal
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES The prevalence of morbid obesity in Korean women has consistently been increasing, while the overall prevalence rate of obesity in Korean women seems to be stable. In addition to bariatric surgery, intragastric balloons (IGBs), as a nonsurgical therapy, have been reported to be effective in weight loss. However, the beneficial effects of IGB in Korean women with obesity have not been fully investigated. The aim of this study was to evaluate the changes in fat mass in Korean women with obesity who had undergone IGB treatment for 6 mon. SUBJECTS/METHODS Seventy-four women with obesity (body mass index [BMI] ≥ 25.0 kg/m2) were recruited. Clinical data, including general information, comorbidities with obesity, anthropometric data, and changes in the body fat composition before and after IGB treatment, were obtained from the subjects. RESULTS Most subjects had one or more comorbidities, such as osteoarthropathy and woman's disease, and had poor eating behaviors, including irregular mealtimes, eating quickly, and frequent overeating. Body composition measurements showed that weight, fat mass, and waist-hip circumference ratio decreased significantly at 6 mon after IGB treatment. In particular, women with morbid obesity (BMI ≥ 30 kg/m2) showed 33% excess weight loss. There was no significant difference in skeletal muscle mass and mineral contents after IGB treatment. CONCLUSIONS This study suggested that 6 mon of IGB treatment can be a beneficial treatment for obesity without muscle mass and bone mineral loss.
Abstract
BACKGROUND/OBJECTIVES The prevalence of morbid obesity in Korean women has consistently been increasing, while the overall prevalence rate of obesity in Korean women seems to be stable. In addition to bariatric surgery, intragastric balloons (IGBs), as a nonsurgical therapy, have been reported to be effective in weight loss. However, the beneficial effects of IGB in Korean women with obesity have not been fully investigated. The aim of this study was to evaluate the changes in fat mass in Korean women with obesity who had undergone IGB treatment for 6 mon. SUBJECTS/METHODS Seventy-four women with obesity (body mass index [BMI] ≥ 25.0 kg/m2) were recruited. Clinical data, including general information, comorbidities with obesity, anthropometric data, and changes in the body fat composition before and after IGB treatment, were obtained from the subjects. RESULTS Most subjects had one or more comorbidities, such as osteoarthropathy and woman's disease, and had poor eating behaviors, including irregular mealtimes, eating quickly, and frequent overeating. Body composition measurements showed that weight, fat mass, and waist-hip circumference ratio decreased significantly at 6 mon after IGB treatment. In particular, women with morbid obesity (BMI ≥ 30 kg/m2) showed 33% excess weight loss. There was no significant difference in skeletal muscle mass and mineral contents after IGB treatment. CONCLUSIONS This study suggested that 6 mon of IGB treatment can be a beneficial treatment for obesity without muscle mass and bone mineral loss.
참고문헌 (49)
- "Fact sheets: obesity and overweight" (2020)[URL]
- Hales CM, "Prevalence of obesity and severe obesity among adults : United States, 2017–2018", NCHS Data Brief, 360, pp.1~8 (2020)
- Korea Health Statistics 2018: Korea National Health and Nutrition Examination Survey, "Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention", Korea Centers for Disease Control and Prevention, ~ (2020)
- Shin HY, "Recent trends in the prevalence of underweight, overweight, and obesity in Korean adults : the Korean National Health and Nutrition Examination Survey from 1998 to 2014", J Epidemiol, 27, pp.413~419 (2017)
- 서미혜, "2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea", Journal of Obesity & Metabolic Syndrome, 28(1), pp.40~45 (2019), 대한비만학회[DOI]
- Preiss K, "A systematic review of variables associated with the relationship between obesity and depression", Obes Rev, 14, pp.906~918 (2013)
- Baranowski T, "Are current health behavioral change models helpful in guiding prevention of weight gain efforts?", Obes Res., 11(Suppl), pp.23S~43S (2003)
- Felson DT, "Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study", Ann Intern Med, 116, pp.535~539 (1992)
- Molyneaux E, "Obesity and mental disorders during pregnancy and postpartum : a systematic review and meta-analysis", Obstet Gynecol, 123, pp.857~867 (2014)
- Neuhouser ML, "Overweight, obesity, and postmenopausal invasive breast cancer risk : a secondary analysis of the women's health initiative randomized clinical trials", JAMA Oncol, 1, pp.611~621 (2015)
- Alhusen JL, "Effects of maternal mental health on engagement in favorable health practices during pregnancy", J Midwifery Womens Health, 61, pp.210~216 (2016)
- Ruban A, "Current treatments for obesity", Clin Med(Lond), 19, pp.205~212 (2019)
- Caudwell P, "Exercise alone is not enough : weight loss also needs a healthy(Mediterranean)diet?", Public Health Nutr, 12, pp.1663~1666 (2009)
- Look AHEAD Research Group, "Eight-year weight losses with an intensive lifestyle intervention : the look AHEAD study", Obesity(Silver Spring), 22, pp.5~13 (2014)
- Sacks FM, "Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates", N Engl J Med, 360, pp.859~873 (2009)
- Mingrone G, "Bariatric surgery versus conventional medical therapy for type 2 diabetes", N Engl J Med, 366, pp.1577~1585 (2012)
- Daniel S, "A complications-based clinical staging of obesity to guide treatment modality and intensity", Curr Opin Endocrinol Diabetes Obes, 20, pp.377~388 (2013)
- Nguyen NT, "Trends in utilization of bariatric surgery, 2009–2012", Surg Endosc, 30, pp.2723~2727 (2016)
- Sullivan S, "Endoscopic bariatric and metabolic therapies : new and emerging technologies", Gastroenterology, 152, pp.1791~1801 (2017)
- Gleysteen JJ, "A history of intragastric balloons", Surg Obes Relat Dis, 12, pp.430~435 (2016)
- Tate CM, "Intragastric balloon treatment for obesity : review of recent studies", Adv Ther, 34, pp.1859~1875 (2017)
- Seong Ji Choi, "Various Intragastric Balloons Under Clinical Investigation", Clinical Endoscopy, 51(5), pp.407~415 (2018), 대한소화기내시경학회
- Cecil RL, "Goldman's Cecil Medicine" (2012), Saunders
- O'Rourke RW, "Inflammation in obesity-related diseases", Surgery, 145, pp.255~259 (2009)
- Gómez R, "What's new in our understanding of the role of adipokines in rheumatic diseases?", Nat Rev Rheumatol, 7, pp.528~536 (2011)
- Garnero P, "Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases", Arthritis Rheum, 43, pp.953~968 (2000)
- Reyes C, "Association between overweight and obesity and risk of clinically diagnosed knee, hip, and hand osteoarthritis : a population-based cohort study", Arthritis Rheumatol, 68, pp.1869~1875 (2016)
- "Obesity fact sheet for Koreans" (2017)[URL]
- Crea N, "Improvement of metabolic syndrome following intragastric balloon : 1 year follow-up analysis", Obes Surg, 19, pp.1084~1088 (2009)
- Suchartlikitwong S, "Usefulness of the ReShape intragastric balloon for obesity", Proc Bayl Univ Med Cent, 32, pp.192~195 (2019)
- Mui WL, "Impact on obesity-related illnesses and quality of life following intragastric balloon", Obes Surg, 20, pp.1128~1132 (2010)
- Hassan NE, "Eating habits and lifestyles among a sample of obese working Egyptian women", Open Access Maced J Med Sci, 3, pp.12~17 (2015)
- 이혜아, "The Effect of Eating Behavior on Being Overweight or Obese During Preadolescence", 예방의학회지, 44(5), pp.226~233 (2011), 대한예방의학회
- Eun Yeong Kang, "Differences in dietary intakes, body compositions, and biochemical indices between metabolically healthy and metabolically abnormal obese Korean women", Nutrition Research and Practice, 13(6), pp.488~497 (2019), 한국영양학회[DOI]
- Kim SH, "Current status of intragastric balloon for obesity treatment", World J Gastroenterol, 22, pp.5495~5504 (2016)
- Buzga M, "Short-term outcomes of the new intragastric balloon End-Ball® for treatment of obesity", Wideochir Inne Tech Maloinwazyjne, 11, pp.229~235 (2016)
- Keren D, "Intragastric balloons for overweight populations 1-year post removal", Obes Surg, 28, pp.2368~2373 (2018)
- Herve J, "What becomes of patients one year after the intragastric balloon has been removed?", Obes Surg, 15, pp.864~870 (2005)
- Angrisani L, "Is bariatric surgery necessary after intragastric balloon treatment?", Obes Surg, 16, pp.1135~1137 (2006)
- Stein EM, "Bone loss after bariatric surgery : causes, consequences, and management", Lancet Diabetes Endocrinol, 2, pp.165~174 (2014)
- Cava E, "Preserving healthy muscle during weight loss", Adv Nutr, 8, pp.511~519 (2017)
- Papageorgiou M, "Is weight loss harmful for skeletal health in obese older adults?", Gerontology, 66, pp.2~14 (2020)
- Fleischer J, "The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss", J Clin Endocrinol Metab, 93, pp.3735~3740 (2008)
- Carrasco F, "Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery", Obes Surg, 19, pp.41~46 (2009)
- Sjöström L, "Effects of bariatric surgery on mortality in Swedish obese subjects", N Engl J Med, 357, pp.741~752 (2007)
- Heber D, "Endocrine and nutritional management of the post-bariatric surgery patient : an Endocrine Society Clinical Practice Guideline", J Clin Endocrinol Metab, 95, pp.4823~4843 (2010)
- Maekawa S, "A comparison of the weight loss effect between a low-carbohydrate diet and a calorie-restricted diet in combination with intragastric balloon therapy", Intern Med, 59, pp.1133~1139 (2020)
- Papalazarou A, "Lifestyle intervention favorably affects weight loss and maintenance following obesity surgery", Obesity(Silver Spring), 18, pp.1348~1353 (2010)
- Molin Netto BD, "Eating patterns and food choice as determinant of weight loss and improvement of metabolic profile after RYGB", Nutrition, 33, pp.125~131 (2017)